ChemAbout
© 2026 ChemAbout
인사이트|개인정보 처리방침|이용약관|[email protected]
홈/화합물/의약 중간체/(Des-Thr7)-Glucagon Trifluoroacetate
C151H219F3N42O49S
3495.7 g/mol
의약 중간체

(Des-Thr7)-Glucagon Trifluoroacetate

CAS1802078-28-9
용도 분류
의약 중간체
화합물 분류
펩타이드
주요 용도
의약 중간체

This compound is a modified peptide of glucagon, specifically lacking the threonine residue at position 7, supplied as a trifluoroacetate salt. It is used as a pharmaceutical intermediate in research and manufacturing settings.

pharmaceutical intermediateresearch compound for peptide studies

콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.

이 화합물을 구매하거나 공급하시겠습니까?

재고를 등록하거나 구매 요청을 게시하세요

CAS 1802078-28-9

이 제품 등록하기
로그인 후 공급 정보 게시
이 제품 구매 요청
가입 없이 요청 제출

관련 화합물

강한 관련구조 유사유사도 0.99

(Des-Thr5)-Glucagon Trifluoroacetate

CAS1802078-27-8

research compound

강한 관련구조 유사유사도 0.88

Glucagonum

CAS16941-32-5

active pharmaceutical ingredient

강한 관련구조 유사유사도 0.86

Glucagon Impurity 4(DG-2)

CAS1037751-81-7

n.a

유사구조 유사유사도 0.84

GLP-1 (7-37)

CAS106612-94-6

active pharmaceutical ingredient

참고동일 카테고리

5-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-3-methyl-1,3-benzoxazol-2(3H)-one

CAS1802149-87-6

Pharmaceutical intermediate for drug synthesis

참고동일 카테고리

Methyl 2-fluoro-4-(1-methoxy-2-methyl-1-oxopropan-2-ylamino)benzoate

CAS1802242-47-2

Pharmaceutical intermediate

참고동일 카테고리

1-(6-chloropyrimidin-4-yl)-3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-methylurea

CAS1802253-30-0

Pharmaceutical intermediate

참고동일 카테고리

Methyl 3-amino-4-(2-methoxy-2-oxoethyl)benzoate

CAS1803562-96-0

pharmaceutical intermediate

식별자
IUPAC 이름

(3S)-3-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]-5-oxopentanoyl]amino]-4-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-1,4-dioxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid;2,2,2-trifluoroacetic acid

InChIKey

SGSPPECWJFSANB-IYXYCECMSA-N

SMILES

C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CNC=N7)N)O.C(=O)(C(F)(F)F)O

동의어 목록 (4)

—